Publication: 4342

Publication: 4342

Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501).

PubMed

DOI

Google Scholar

Citation:: Ann Surg Oncol vol 31 (10) 7033-42

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 14

Parents:: 3911 4162
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882; UG1CA189850, UG1CA233290, UG1CA233329, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG)

Corr. Author:
Authors:: Rebecca A Snyder Tyler J Zemla Qian Shi Diana Segovia Syed A Ahmad Eileen M O'Reilly Joseph M Herman Matthew H G Katz

Networks:: LAPS-NY016, LAPS-TX035, NORTHWELL, OH070

Study: Alliance-A021501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: